Cellular and molecular therapies
AssigneeThe University Court of the University of Glasgow
InventorPaul Shiels
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe University Court of the University of Glasgow
InventorPaul Shiels
Estimating the term…
The present invention provides, among other things, improved compositions and methods for the treatment of tissue damage (e.g., acute or chronic) and related diseases, disorders or conditions based on the use of pathfinder cells, extracellular secretomes thereof, and/or pathfinder cell-associated microRNAs. In some embodiments, the present invention provides a method for treating tissue damage (e.g., acute or chronic) comprising a step of administering a population of cells to an individual suffering from a disease, disorder or condition characterized by acute damage to one or more tissues, wherein the cells are originated from an adult tissue and wherein the cells induce tissue repair, regeneration, remodeling, reconstitution or differentiation. In some embodiments, the present invention provides a method for treating inflammation comprising a step of administering a population of cells, or extracellular secretomes thereof, to an individual suffering from a disease, disorder or condition characterized by inflammation of one or more tissues, wherein the cells are originated from an adult tissue and wherein the cells induce an anti-inflammatory response.
A method for treating acute tissue damage comprising a step of:
The method of, wherein the adult tissue is a non-human adult tissue.
The method of any one of the preceding claims, wherein at least 50% of the population of cells express one or more markers selected from the group consisting of CD24, c-myc, HLA class 1 ABC, ICAM3, Nestin, Nanog, Oct4, Integrin α2+b1, Ngn3, and CD130.
-19. (canceled)
-73. (canceled)
Dependencies are inferred from the claim text.